Investigating Mycobacterium tuberculosis L, D-transpeptidases as novel drug targets

被引：0
|
作者：
Basta, Leighanne [1 ]
Pan, Ying [2 ]
Kaushik, Amit [3 ]
Lloyd, Evan [4 ]
Townsend, Craig [4 ]
Staker, Bart [5 ]
Lukacs, Christine [6 ]
Bianchet, Mario [2 ]
Lamichhane, Gyanu [3 ]
机构：
[1] US Naval Acad, Chem, Annapolis, MD 21402 USA
[2] Johns Hopkins Univ, Sch Med, Biophys & Biophys Chem, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Med Infect Dis, Baltimore, MD USA
[4] Johns Hopkins Univ, Chem, Baltimore, MD USA
[5] Ctr Infect Dis Res, Seattle, WA USA
[6] Elpedira, Cambridge, MA USA
来源：
FASEB JOURNAL | 2016年 / 30卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
613.6
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Cleavage of Braun's lipoprotein Lpp from the bacterial peptidoglycan by a paralog of L,D-transpeptidases, LdtF
    Bahadur, Raj
    Chodisetti, Pavan Kumar
    Reddy, Manjula
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (19)
  • [32] Phylogenetic and Biochemical Analyses of Mycobacterial L,D-Transpeptidases Reveal a Distinct Enzyme Class That Is Preferentially Acylated by Meropenem
    Zandi, Trevor A.
    Marshburn, Robert L.
    Stateler, Paige K.
    Basta, Leighanne A. Brammer
    ACS INFECTIOUS DISEASES, 2019, 5 (12): : 2047 - 2054
  • [33] Adenylating Enzymes in Mycobacterium tuberculosis as Drug Targets
    Duckworth, Benjamin P.
    Nelson, Kathryn M.
    Aldrich, Courtney C.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2012, 12 (07) : 766 - 796
  • [34] The Expanding Diversity of Mycobacterium tuberculosis Drug Targets
    Wellington, Samantha
    Hung, Deborah T.
    ACS INFECTIOUS DISEASES, 2018, 4 (05): : 696 - 714
  • [35] Clostridioides difficile canonical L,D-transpeptidases catalyze a novel type of peptidoglycan cross-links and are not required for beta-lactam resistance
    Galley, Nicola F.
    Greetham, Darren
    Alaman-Zarate, Marcel G.
    Williamson, Mike P.
    Evans, Caroline A.
    Spittal, William D.
    Buddle, Jessica E.
    Freeman, Jane
    Davis, Georgina L.
    Dickman, Mark J.
    Wilcox, Mark H.
    Lovering, Andrew L.
    Fagan, Robert P.
    Mesnage, Stephane
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (01)
  • [36] Identification of new drug targets in Mycobacterium avium and Mycobacterium tuberculosis
    Rastogi, N
    Goh, KS
    VanGinkel, SZ
    Wright, EL
    Barrow, WW
    RESEARCH IN MICROBIOLOGY, 1996, 147 (1-2) : 97 - 105
  • [37] Peptidoglycan Cross-Linking Activity of L,D-Transpeptidases from Clostridium difficile and Inactivation of These Enzymes by β-Lactams
    Sutterlin, Laetitia
    Edoo, Zainab
    Hugonnet, Jean-Emmanuel
    Mainardi, Jean-Luc
    Arthur, Michel
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (01)
  • [38] The β-Carbonic Anhydrases from Mycobacterium tuberculosis as Drug Targets
    Nishimori, Isao
    Minakuchi, Tomoko
    Maresca, Alfonso
    Carta, Fabrizio
    Scozzafava, Andrea
    Supuran, Claudiu T.
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (29) : 3300 - 3309
  • [39] Structural and functional studies of drug targets for Mycobacterium tuberculosis
    Rao, Z.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2017, 46 : S171 - S171
  • [40] Proteases in Mycobacterium tuberculosis pathogenesis: potential as drug targets
    Roberts, David M.
    Personne, Yoann
    Ollinger, Juliane
    Parish, Tanya
    FUTURE MICROBIOLOGY, 2013, 8 (05) : 621 - 631
12345